<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Global Spine J</journal-id><journal-id journal-id-type="iso-abbrev">Global Spine J</journal-id><journal-id journal-id-type="pmc-domain-id">2276</journal-id><journal-id journal-id-type="pmc-domain">gsj</journal-id><journal-id journal-id-type="publisher-id">GSJ</journal-id><journal-title-group><journal-title>Global Spine Journal</journal-title></journal-title-group><issn pub-type="ppub">2192-5682</issn><issn pub-type="epub">2192-5690</issn><publisher><publisher-name>SAGE Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10802539</article-id><article-id pub-id-type="pmcid-ver">PMC10802539.1</article-id><article-id pub-id-type="pmcaid">10802539</article-id><article-id pub-id-type="pmcaiid">10802539</article-id><article-id pub-id-type="pmid">35603925</article-id><article-id pub-id-type="doi">10.1177/21925682221104731</article-id><article-id pub-id-type="publisher-id">10.1177_21925682221104731</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>The Drivers of Persistent Opioid Use and Its Impact on Healthcare Utilization After Elective Spine Surgery</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5992-9119</contrib-id><name name-style="western"><surname>Gerlach</surname><given-names initials="EB">Erik B.</given-names></name><degrees>MD</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Plantz</surname><given-names initials="MA">Mark A.</given-names></name><degrees>MD</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Swiatek</surname><given-names initials="PR">Peter R.</given-names></name><degrees>MD</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="SA">Scott A.</given-names></name><degrees>BS</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Arpey</surname><given-names initials="N">Nicholas</given-names></name><degrees>MD</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4485-8274</contrib-id><name name-style="western"><surname>Fei-Zhang</surname><given-names initials="D">David</given-names></name><degrees>BA</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-5776-2044</contrib-id><name name-style="western"><surname>Divi</surname><given-names initials="SN">Srikanth N.</given-names></name><degrees>MD</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hsu</surname><given-names initials="WK">Wellington K.</given-names></name><degrees>MD</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Patel</surname><given-names initials="AA">Alpesh A.</given-names></name><degrees>MD, MBA</degrees><xref rid="aff1-21925682221104731" ref-type="aff">1</xref></contrib><aff id="aff1-21925682221104731"><label>1</label>Department of Orthopaedic Surgery, <institution-wrap><institution-id institution-id-type="Ringgold">12244</institution-id><institution content-type="university">Northwestern University</institution></institution-wrap>, Chicago, IL, USA</aff></contrib-group><author-notes><corresp id="corresp1-21925682221104731">Erik B. Gerlach, MD, Department of Orthopaedic Surgery, 676 N. St. Clair St., Suite 1350, Northwestern University, Chicago, IL 60611, USA. Email: <email>erik.gerlach@northwestern.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>5</month><year>2022</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2024</year></pub-date><volume>14</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">453882</issue-id><fpage>370</fpage><lpage>379</lpage><pub-history><event event-type="pmc-release"><date><day>23</day><month>05</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>23</day><month>01</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-21 22:25:29.390"><day>21</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder content-type="sage">AO Spine, unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>) which permits non-commercial use, reproduction and distribution of the work as published without adaptation or alteration, without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="10.1177_21925682221104731.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="10.1177_21925682221104731.pdf"/><abstract><sec><title>Study Design</title><p>Retrospective cohort study</p></sec><sec><title>Objective</title><p>The aim of this study was to determine the incidence of and risk factors for persistent opioid use after elective cervical and lumbar spine procedures and to quantify postoperative healthcare utilization in this patient population.</p></sec><sec><title>Methods</title><p>Patients were retrospectively identified who underwent elective spine surgery for either cervical or lumbar degenerative pathology between November 1, 2013, and September 30, 2018, at a single academic center. Patients were split into 2 cohorts, including patients with and without opioid use at 180-days postoperatively. Baseline patient demographics, underlying comorbidities, surgical variables, and preoperative/postoperative opioid use were assessed. Health resource utilization metrics within 1 year postoperatively (ie, imaging studies, emergency and urgent care visits, hospital readmissions, opioid prescriptions, etc.) were compared between these 2 groups.</p></sec><sec><title>Results</title><p>583 patients met inclusion criteria, of which 16.6% had opioid persistence after surgery. Opioid persistence was associated with ASA score &#8805;3 (P = .004), diabetes (<italic toggle="yes">P</italic> = .019), class I obesity (<italic toggle="yes">P</italic> = .012), and an opioid prescription in the 60 days prior to surgery (<italic toggle="yes">P</italic> = .006). Independent risk factors for opioid persistence assessed via multivariate regression included multi-level lumbar fusion (RR = 2.957), cervical central stenosis (RR = 2.761), and pre-operative opioid use (RR = 2.668). Opioid persistence was associated with higher rates of health care utilization, including more radiographs (<italic toggle="yes">P</italic> &lt; .001), computed tomography (CT) scans (.007), magnetic resonance imaging (MRI) studies (<italic toggle="yes">P</italic> = .014), emergency department (ED) visits (.009), pain medicine referrals (P &lt; .001), and spinal injections (<italic toggle="yes">P</italic> = .003).</p></sec><sec><title>Conclusions</title><p>Opioid persistence is associated with higher rates of health care utilization within 1 year after elective spine surgery.</p></sec></abstract><kwd-group><kwd>opioid</kwd><kwd>spine surgery</kwd><kwd>healthcare utilization</kwd><kwd>healthcare resources</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>typesetter</meta-name><meta-value>ts10</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec6-21925682221104731"><title>Introduction</title><p>As of 2017, the cost of opioid use disorder and fatal opioid overdose was estimated to exceed $1.02 trillion, with the primary economic burden stemming from reduced quality of life and value of life lost due to overdose and death.<sup>
<xref rid="bibr1-21925682221104731" ref-type="bibr">1</xref>
</sup> A multitude of factors have contributed to the current crisis, including opioid misuse, opioid abuse, inappropriate prescribing patterns, and a lack of understanding of adverse effects associated with long-term opioid use.<sup>
<xref rid="bibr2-21925682221104731" ref-type="bibr">2</xref>
</sup> Surgical patients are uniquely enveloped in the opioid crisis, as surgeons and health care providers routinely prescribe opioids for management of acute postoperative pain in both opioid-na&#239;ve patients and those with prior opioid use. For both groups of patients, surgery represents a critical exposure event that increases the risk of developing opioid persistence or dependence.<sup><xref rid="bibr3-21925682221104731" ref-type="bibr">3</xref>,<xref rid="bibr4-21925682221104731" ref-type="bibr">4</xref></sup> Risk factors in surgical patients younger age, smoking, chronic pulmonary disease, fibromyalgia, psychiatric or medical co-morbidities, prior benzodiazepine use, prior opioid use, and extent of operation.<sup><xref rid="bibr4-21925682221104731" ref-type="bibr">4</xref>-<xref rid="bibr9-21925682221104731" ref-type="bibr">9</xref></sup></p><p>Patients undergoing spine surgery are at particularly increased risk of developing post-surgical opioid dependence, with 6% to 18% of opioid-na&#239;ve patients<sup><xref rid="bibr3-21925682221104731" ref-type="bibr">3</xref>,<xref rid="bibr10-21925682221104731" ref-type="bibr">10</xref></sup> and of 52% to 64% of patients with prior opioid-use <sup>
<xref rid="bibr11-21925682221104731" ref-type="bibr">11</xref>
</sup> developing opioid persistence. These worryingly high percentages of persistent opioid use may partially be explained by persistent pain after surgery. However, some studies suggest that patients may also be taking opioid medications for reasons other than pain control, such as difficulty sleeping, and may continue taking opioids to avoid experiencing withdrawal symptoms <sup><xref rid="bibr12-21925682221104731" ref-type="bibr">12</xref>-<xref rid="bibr14-21925682221104731" ref-type="bibr">14</xref></sup> Despite our understanding that patient undergoing spine surgery are generally at increased risk of developing persistent opioid use after their operation, the downstream impact of various opioid use patterns on health care utilization after spine surgery has not been well-established. For example, our review of the literature returned only 2 studies that established a relationship between opioid dependence and increased health care utilization up to 15 months after surgery for adult degenerative scoliosis<sup>
<xref rid="bibr15-21925682221104731" ref-type="bibr">15</xref>
</sup> and degenerative lumbar spondylolisthesis.<sup>
<xref rid="bibr16-21925682221104731" ref-type="bibr">16</xref>
</sup> To our knowledge, no study has comprehensively investigated the relationship between opioid persistence in cervical and lumbar spine surgery patients and postoperative health care resource utilization.</p><p>The primary purpose this study was to determine the impact of opioid persistence, as defined as at least 1 new opioid prescription after 180 days postoperatively, on post-operative health care utilization in patients undergoing cervical and lumbar spine surgery. Secondary objectives included quantifying the incidence of opioid persistence in patients undergoing cervical and lumbar spine surgery and identifying key predictive and protective factors associated with opioid persistence. We hypothesized that cervical and lumbar patients with opioid persistence would use more health care resources compared to their counterparts who successfully weaned off any postoperative opioid medications.</p></sec><sec sec-type="methods" id="sec7-21925682221104731"><title>Methods</title><sec id="sec8-21925682221104731"><title>Study Population</title><p>This study was approved by the Institutional Review Board (IRB) and a waiver of informed consent was granted. A sample of 583 patients who underwent elective spine surgery between November 1, 2013, and September 30, 2018, were retrospectively identified. All patients underwent surgery by 1 of 3 fellowship-trained orthopaedic spine surgeons at our institution.</p></sec><sec id="sec9-21925682221104731"><title>Inclusion/Exclusion Criteria</title><p>Patients were eligible if they were at least 18 years of age and underwent decompression or decompression and fusion for degenerative cervical or lumbar spine disorders with a minimum follow-up of at least 1 year postoperatively. Patients were excluded if they had a non-degenerative diagnosis or underwent emergent surgery. We chose to focus on the degenerative spine population because these patients, in addition to being most prevalent, most commonly received non-operative care prior to surgery. Therefore, we had an opportunity to track opioid use prior to surgery. Tracking opioid use for patients prior to emergency surgery was more variable; therefore, this patient population was excluded. Additionally, patients were excluded if they underwent a fusion of more than 6 levels, as the extent of surgery would make comparison to other degenerative spine patients more challenging.</p></sec><sec id="sec10-21925682221104731"><title>Predictor Variables</title><p>Several patient and surgical variables have been previously reported as potential predictors for persistent opioid use following surgery were collected. <sup><xref rid="bibr4-21925682221104731" ref-type="bibr">4</xref>-<xref rid="bibr8-21925682221104731" ref-type="bibr">8</xref></sup> Patient variables included sex, age, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, Charlson comorbidity index (CCI)<sup>
<xref rid="bibr17-21925682221104731" ref-type="bibr">17</xref>
</sup> (<xref rid="table1-21925682221104731" ref-type="table">Table 1</xref>), medical comorbidities, and opioid prescriptions within the 60 days prior to surgery. Patient comorbidities included diabetes, congestive heart failure (CHF), peripheral vascular disease (PVD), renal disease, and moderate-severe liver disease. Age was stratified as follows: 18-30, 30-39, 40-49, 50-59, 60-69, and 70+ years old. BMI was stratified as follows: underweight (&lt;18.5), normal (18.5-24.9), overweight (25.0-29.9), obesity class I (30.0-34.9), obesity class II (35.0-39.9), obesity class III (40.0+).<sup>
<xref rid="bibr18-21925682221104731" ref-type="bibr">18</xref>
</sup><table-wrap position="float" id="table1-21925682221104731" orientation="portrait"><label>Table 1.</label><caption><p>Charlson Comorbidity Index (modified)</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table1-21925682221104731" position="float" orientation="portrait" xlink:href="10.1177_21925682221104731-table1.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">Medical Condition</th><th align="center" rowspan="1" colspan="1">Weight for calculation</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Cerebrovascular disease</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic pulmonary disease</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Congestive heart failure</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Connective tissue disease</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Dementia</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Depression</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild liver disease</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Myocardial infarction</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral vascular disease</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Ulcer disease</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Use of warfarin</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Hemiplegia</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate or severe renal disease</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes with end organ damage</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Any tumor</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Leukemia</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphoma</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Skin ulcers/cellulitis</td><td align="center" rowspan="1" colspan="1">2</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate or severe liver disease</td><td align="center" rowspan="1" colspan="1">3</td></tr><tr><td align="left" rowspan="1" colspan="1">Metastatic cancer</td><td align="center" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">AIDS</td><td align="center" rowspan="1" colspan="1">6</td></tr></tbody></table></alternatives></table-wrap></p><p>The ASA classification is a tool used to describe and categorize a patient&#8217;s physiological status<sup>
<xref rid="bibr13-21925682221104731" ref-type="bibr">13</xref>
</sup>. It has also been shown to be useful in predicting operative risk<sup><xref rid="bibr19-21925682221104731" ref-type="bibr">19</xref>,<xref rid="bibr20-21925682221104731" ref-type="bibr">20</xref></sup>. ASA scores range from I to VI, in order of worsening health. The CCI is a scoring system that was initially proposed to predict a patient&#8217;s mortality within 1 year of hospitalization.<sup>
<xref rid="bibr21-21925682221104731" ref-type="bibr">21</xref>
</sup> The CCI scoring system estimates the degree of a patient&#8217;s comorbidity burden; it has been used extensively as a predictor of poor outcomes following a variety of orthopaedic procedures.<sup><xref rid="bibr22-21925682221104731" ref-type="bibr">22</xref>-<xref rid="bibr24-21925682221104731" ref-type="bibr">24</xref></sup></p></sec><sec id="sec11-21925682221104731"><title>Outcome Variables</title><p>The number of postoperative opioid prescriptions were totaled at 3 time points: 1) within 90 days, 2) between 90-180 days, and 3) between 180-365 days postoperatively. The electronic medical record (EMR) pertaining to the institution, surrounding academic and private hospital systems participating in the health information exchange platform were reviewed for all opioid prescriptions and healthcare resources utilized.<sup>
<xref rid="bibr25-21925682221104731" ref-type="bibr">25</xref>
</sup> New opioid prescriptions were recorded if the indication was related to postoperative pain. Healthcare resources were recorded if the indication was for routine follow-up or diagnostic workup. Refill orders were reported as a separate prescription. The dose and type of opioid prescribed was not reported. Rather, the total number of opioid prescriptions was used as a proxy for the overall opioid burden for each patient. The main measure of persistent opioid use after surgery was defined as at least 1 new opioid prescription after 180 days postoperatively.</p></sec><sec id="sec12-21925682221104731"><title>Healthcare Utilization Metrics</title><p>Various metrics of healthcare utilization in the first year after index surgery were reported for each patient in the cohort. These included the number of imaging studies &#8211; including radiographs (XR), computed tomography (CT) scans, and magnetic resonance imaging (MRI) studies) &#8211; emergency department visits, urgent care visits, pain management referrals, and epidural or other spinal injections.</p></sec><sec id="sec13-21925682221104731"><title>Statistical Analysis</title><p>All data was analyzed using the IBM SPSS Version 24 software package (IBM Corporation, Armonk, NY). Chi-squared and Fisher&#8217;s exact test, where appropriate, were used to compare categorical predictor variables between patients with and without opioid persistence at 6 months postoperatively. For univariate analysis, sequential binary logistic regression was used to calculate risk ratios (RR) for opioid persistence at 6 months for each individual predictor variable. Variables that were found to be significant in the univariate analysis were included in a multivariate binary logistic regression. Statistical significance was defined as <italic toggle="yes">P</italic> &lt; .05 for all tests.</p></sec></sec><sec sec-type="results" id="sec14-21925682221104731"><title>Results</title><p>Of the 583 patients included, the majority were male (53.9%) and the average age was 55.3. 153 patients underwent cervical spine surgery compared to 430 patients who underwent lumbar spine surgery. (<xref rid="table2-21925682221104731" ref-type="table">Table 2</xref>). 97 patients (16.6%) had persistent opioid use at 6 months postoperatively. The patients with opioid persistence were more likely to have class I obesity (<italic toggle="yes">P</italic> = .021), an ASA classification score of 3 or greater (<italic toggle="yes">P</italic> = .004), a history of diabetes (<italic toggle="yes">P</italic> = .030), and an opioid prescription in the 60 days prior to surgery (<italic toggle="yes">P</italic> = .008). These patients were also less likely to have a CCI score of 0 (<italic toggle="yes">P</italic> = .035).<table-wrap position="float" id="table2-21925682221104731" orientation="portrait"><label>Table 2.</label><caption><p>Patient Demographics, Comorbidities, and Pre-operative Opioid Use</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table2-21925682221104731" position="float" orientation="portrait" xlink:href="10.1177_21925682221104731-table2.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="2" colspan="1"/><th align="center" colspan="2" rowspan="1">No Opioid Persistence<sup>
<xref rid="table-fn1-21925682221104731" ref-type="table-fn">1</xref>
</sup> [n = 486]</th><th align="center" colspan="2" rowspan="1">Opioid Persistence<sup>
<xref rid="table-fn1-21925682221104731" ref-type="table-fn">1</xref>
</sup> [n = 97]</th><th align="center" rowspan="2" colspan="1">p</th></tr><tr><th align="left" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">53.9</td><td align="center" rowspan="1" colspan="1">262</td><td align="center" rowspan="1" colspan="1">56.7</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">.614</td></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="center" rowspan="1" colspan="1">46.1</td><td align="center" rowspan="1" colspan="1">224</td><td align="center" rowspan="1" colspan="1">43.3</td><td align="center" rowspan="1" colspan="1">42</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Under 18</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" rowspan="1" colspan="1">18-30</td><td align="center" rowspan="1" colspan="1">7.4</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">3.1</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">.120</td></tr><tr><td align="left" rowspan="1" colspan="1">30-39</td><td align="center" rowspan="1" colspan="1">13.6</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">12.4</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">.749</td></tr><tr><td align="left" rowspan="1" colspan="1">40-49</td><td align="center" rowspan="1" colspan="1">13.2</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">18.6</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">.163</td></tr><tr><td align="left" rowspan="1" colspan="1">50-59</td><td align="center" rowspan="1" colspan="1">20.4</td><td align="center" rowspan="1" colspan="1">99</td><td align="center" rowspan="1" colspan="1">22.7</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">.609</td></tr><tr><td align="left" rowspan="1" colspan="1">60-69</td><td align="center" rowspan="1" colspan="1">25.7</td><td align="center" rowspan="1" colspan="1">125</td><td align="center" rowspan="1" colspan="1">23.7</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">.678</td></tr><tr><td align="left" rowspan="1" colspan="1">Over 70</td><td align="center" rowspan="1" colspan="1">19.8</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">19.6</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">.970</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI Class</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Underweight (&lt;18.5)</td><td align="center" rowspan="1" colspan="1">0.8</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">1.0</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">&gt;.999</td></tr><tr><td align="left" rowspan="1" colspan="1">Normal Weight (18.5 &#8211; 24.9)</td><td align="center" rowspan="1" colspan="1">25.3</td><td align="center" rowspan="1" colspan="1">123</td><td align="center" rowspan="1" colspan="1">21.6</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">.445</td></tr><tr><td align="left" rowspan="1" colspan="1">Overweight (25.0 &#8211; 29.9)</td><td align="center" rowspan="1" colspan="1">38.9</td><td align="center" rowspan="1" colspan="1">189</td><td align="center" rowspan="1" colspan="1">33.0</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">.274</td></tr><tr><td align="left" rowspan="1" colspan="1">Obese Class I (30.0 &#8211; 34.9)</td><td align="center" rowspan="1" colspan="1">18.5</td><td align="center" rowspan="1" colspan="1">90</td><td align="center" rowspan="1" colspan="1">28.9</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">.021</td></tr><tr><td align="left" rowspan="1" colspan="1">Obese Class II (34.9 &#8211; 39.9)</td><td align="center" rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">7.2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">.212</td></tr><tr><td align="left" rowspan="1" colspan="1">Obese Class III (40.0 +)</td><td align="center" rowspan="1" colspan="1">4.9</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">8.2</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">.191</td></tr><tr><td align="left" rowspan="1" colspan="1">ASA Class</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">I</td><td align="center" rowspan="1" colspan="1">13.8</td><td align="center" rowspan="1" colspan="1">67</td><td align="center" rowspan="1" colspan="1">7.2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">.076</td></tr><tr><td align="left" rowspan="1" colspan="1">II</td><td align="center" rowspan="1" colspan="1">62.8</td><td align="center" rowspan="1" colspan="1">305</td><td align="center" rowspan="1" colspan="1">55.7</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">.190</td></tr><tr><td align="left" rowspan="1" colspan="1">III</td><td align="center" rowspan="1" colspan="1">23.0</td><td align="center" rowspan="1" colspan="1">112</td><td align="center" rowspan="1" colspan="1">37.1</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">.004</td></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" rowspan="1" colspan="1">Charlson Comorbidity Index (CCI)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">CCI = 0</td><td align="center" rowspan="1" colspan="1">23.0</td><td align="center" rowspan="1" colspan="1">112</td><td align="center" rowspan="1" colspan="1">13.4</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">.035</td></tr><tr><td align="left" rowspan="1" colspan="1">CCI = 1</td><td align="center" rowspan="1" colspan="1">19.3</td><td align="center" rowspan="1" colspan="1">94</td><td align="center" rowspan="1" colspan="1">20.6</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">.772</td></tr><tr><td align="left" rowspan="1" colspan="1">CCI &gt;= 2</td><td align="center" rowspan="1" colspan="1">57.6</td><td align="center" rowspan="1" colspan="1">280</td><td align="center" rowspan="1" colspan="1">66.0</td><td align="center" rowspan="1" colspan="1">64</td><td align="center" rowspan="1" colspan="1">.126</td></tr><tr><td align="left" rowspan="1" colspan="1">Comorbidities</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="center" rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">19.6</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">.030</td></tr><tr><td align="left" rowspan="1" colspan="1">Congestive heart failure (CHF)</td><td align="center" rowspan="1" colspan="1">3.7</td><td align="center" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">7.2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">.117</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic pulmonary disease</td><td align="center" rowspan="1" colspan="1">13.6</td><td align="center" rowspan="1" colspan="1">66</td><td align="center" rowspan="1" colspan="1">28.9</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">&lt;.001</td></tr><tr><td align="left" rowspan="1" colspan="1">Peripheral vascular disease (PVD)</td><td align="center" rowspan="1" colspan="1">6.0</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">8.2</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">.385</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal disease</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">4.1</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">.212</td></tr><tr><td align="left" rowspan="1" colspan="1">Opioid Rx in 60 Days Prior to Surgery</td><td align="center" rowspan="1" colspan="1">68.3</td><td align="center" rowspan="1" colspan="1">332</td><td align="center" rowspan="1" colspan="1">82.5</td><td align="center" rowspan="1" colspan="1">80</td><td align="center" rowspan="1" colspan="1">.008</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="table-fn1-21925682221104731"><p><sup>1</sup>Defined as new opioid prescriptions between 180 &#8211; 365 days postoperatively</p></fn></table-wrap-foot></table-wrap></p><p>Additionally, surgical indication and intensity were both associated with persistent opioid use postoperatively. Patients undergoing procedures for cervical central stenosis were more likely to have persistent opioid use postoperatively (<italic toggle="yes">P</italic> = .004). Patients undergoing procedures for lumbar disc herniation were less likely to have persistent opioid use postoperatively (<italic toggle="yes">P</italic> = .043). Patients with opioid persistence were more likely to have undergone multi-level lumbar arthrodesis (<italic toggle="yes">P</italic> = .022) and multi-level cervical arthrodesis (<italic toggle="yes">P</italic> = .003), and they were less likely to have undergone lumbar decompression alone (<italic toggle="yes">P</italic> = .027) (<xref rid="table3-21925682221104731" ref-type="table">Table 3</xref>).<table-wrap position="float" id="table3-21925682221104731" orientation="portrait"><label>Table 3.</label><caption><p>Surgical Variables</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table3-21925682221104731" position="float" orientation="portrait" xlink:href="10.1177_21925682221104731-table3.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="2" colspan="1"/><th align="center" colspan="2" rowspan="1">No Opioid Persistence<break/>[n = 486]</th><th align="center" colspan="2" rowspan="1">Opioid Persistence<break/>[n = 97]</th><th align="center" rowspan="2" colspan="1">p</th></tr><tr><th align="left" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Indication(s)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Cervical</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Disc herniation</td><td align="center" rowspan="1" colspan="1">11.3%</td><td align="center" rowspan="1" colspan="1">55</td><td align="center" rowspan="1" colspan="1">11.3%</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">.995</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Spondylolisthesis</td><td align="center" rowspan="1" colspan="1">.8%</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">3.1%</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">.094</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Foraminal stenosis</td><td align="center" rowspan="1" colspan="1">18.9%</td><td align="center" rowspan="1" colspan="1">92</td><td align="center" rowspan="1" colspan="1">26.8%</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">.078</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Central stenosis</td><td align="center" rowspan="1" colspan="1">12.6%</td><td align="center" rowspan="1" colspan="1">61</td><td align="center" rowspan="1" colspan="1">23.7%</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">.004</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Lumbar</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Disc herniation</td><td align="center" rowspan="1" colspan="1">35.4%</td><td align="center" rowspan="1" colspan="1">172</td><td align="center" rowspan="1" colspan="1">24.7%</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">.043</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Spondylolisthesis</td><td align="center" rowspan="1" colspan="1">22.8%</td><td align="center" rowspan="1" colspan="1">111</td><td align="center" rowspan="1" colspan="1">25.8%</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">.533</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Foraminal stenosis</td><td align="center" rowspan="1" colspan="1">44.0%</td><td align="center" rowspan="1" colspan="1">214</td><td align="center" rowspan="1" colspan="1">49.5%</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">.324</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Central stenosis</td><td align="center" rowspan="1" colspan="1">36.6%</td><td align="center" rowspan="1" colspan="1">178</td><td align="center" rowspan="1" colspan="1">39.2%</td><td align="center" rowspan="1" colspan="1">38</td><td align="center" rowspan="1" colspan="1">.635</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Lumbar</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;0 levels (decompression only)</td><td align="center" rowspan="1" colspan="1">49.4</td><td align="center" rowspan="1" colspan="1">240</td><td align="center" rowspan="1" colspan="1">37.1</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">.027</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;1-level</td><td align="center" rowspan="1" colspan="1">19.8</td><td align="center" rowspan="1" colspan="1">96</td><td align="center" rowspan="1" colspan="1">16.5</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">.457</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Multi-level</td><td align="center" rowspan="1" colspan="1">6.6</td><td align="center" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">13.4</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">.022</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Cervical</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;0 levels (decompression only)</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">.998</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;1-level</td><td align="center" rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">56</td><td align="center" rowspan="1" colspan="1">9.3</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">.521</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Multi-level</td><td align="center" rowspan="1" colspan="1">1.7</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">21.6</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">.003</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Lumbar</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Decompression-only</td><td align="center" rowspan="1" colspan="1">49.4</td><td align="center" rowspan="1" colspan="1">240</td><td align="center" rowspan="1" colspan="1">37.1</td><td align="center" rowspan="1" colspan="1">36</td><td align="center" rowspan="1" colspan="1">.027</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;PLF/PSF</td><td align="center" rowspan="1" colspan="1">5.3</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">7.2</td><td align="center" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">.467</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;TLIF/PLIF</td><td align="center" rowspan="1" colspan="1">11.1</td><td align="center" rowspan="1" colspan="1">54</td><td align="center" rowspan="1" colspan="1">17.5</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">.067</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;ALIF</td><td align="center" rowspan="1" colspan="1">4.1</td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">3.1</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">.637</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;LLIF</td><td align="center" rowspan="1" colspan="1">5.1</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">5.2</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">.783</td></tr><tr><td align="left" rowspan="1" colspan="1">Cervical</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Decompression-only</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">2.1</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">.998</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Posterior cervical fusion</td><td align="center" rowspan="1" colspan="1">.4</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">6.2</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">.001</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Anterior cervical discectomy &amp;</td><td align="center" rowspan="1" colspan="1">21.6</td><td align="center" rowspan="1" colspan="1">105</td><td align="center" rowspan="1" colspan="1">25.8</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">.368</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;fusion (ACDF)</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;&#8195;Revision Surgery</td><td align="center" rowspan="1" colspan="1">7.2</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">8.2</td><td align="center" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">.719</td></tr></tbody></table></alternatives></table-wrap></p><p>Univariate binary logistic regression suggested the following variables were risk factors for opioid persistence: ASA class 3+ (RR = 2.186, 95% CI: 1.241 &#8211; 3.131), history of diabetes (RR = 2.266, 95% CI: 1.109 &#8211; 3.422), an opioid prescription within 60-days prior to surgery (RR = 2.438, 95% CI: 1.226 &#8211; 3.649), cervical central stenosis (RR = 2.438, CI: 1.263 &#8211; 3.714), and multi-level lumbar (RR = 2.731, 95% CI: 1.106 &#8211; 4.357) or multi-level cervical arthrodesis (RR = 2.681, 95% CI: 1.314 &#8211; 4.047). Additionally, a CCI of 0 (RR = .620, 95% CI: .278 &#8211; .962), lumbar disc herniation (RR = .676, CI: .365 &#8211; .987), and simple lumbar decompression (RR = .667, 95% CI: .386 &#8211; .947) were associated with a decreased risk of opioid persistence (<xref rid="table4-21925682221104731" ref-type="table">Table 4</xref>).<table-wrap position="float" id="table4-21925682221104731" orientation="portrait"><label>Table 4.</label><caption><p>Univariate Analysis of Risk Factors for Opioid Persistence</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table4-21925682221104731" position="float" orientation="portrait" xlink:href="10.1177_21925682221104731-table4.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Risk Ratio [95% C.I.]</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">Male</td><td align="center" rowspan="1" colspan="1">.721 &#8211; 1.737</td></tr><tr><td align="left" rowspan="1" colspan="1">Age (years)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Under 18</td><td align="center" rowspan="1" colspan="1">&#8211;</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;18-30</td><td align="center" rowspan="1" colspan="1">.120 &#8211; 1.323</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;30-39</td><td align="center" rowspan="1" colspan="1">.465 &#8211; 1.734</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;40-49</td><td align="center" rowspan="1" colspan="1">.845 &#8211; 2.671</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;50-59</td><td align="center" rowspan="1" colspan="1">.679 &#8211; 1.936</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;60-69</td><td align="center" rowspan="1" colspan="1">.539 &#8211; 1.495</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Over 70</td><td align="center" rowspan="1" colspan="1">.572 &#8211; 1.713</td></tr><tr><td align="left" rowspan="1" colspan="1">BMI Class</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Underweight (&lt;18.5)</td><td align="center" rowspan="1" colspan="1">.139 &#8211; 11.354</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Normal Weight (18.5 &#8211; 24.9)</td><td align="center" rowspan="1" colspan="1">.483 &#8211; 1.378</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Overweight (25.0 &#8211; 29.9)</td><td align="center" rowspan="1" colspan="1">.488 &#8211; 1.227</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Obese (30.0+)</td><td align="center" rowspan="1" colspan="1">.952 &#8211; 2.303</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">ASA Class</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;I</td><td align="center" rowspan="1" colspan="1">.914 &#8211; 4.627</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;II</td><td align="center" rowspan="1" colspan="1">.480 &#8211; 1.158</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;III+</td><td align="center" rowspan="1" colspan="1">1.241 &#8211; 3.131</td></tr><tr><td align="left" rowspan="1" colspan="1">Charlson Comorbidity Index (CCI)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;CCI = 0</td><td align="center" rowspan="1" colspan="1">.278 &#8211; .962</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;CCI = 1</td><td align="center" rowspan="1" colspan="1">.631 &#8211; 1.860</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;CCI = 2+</td><td align="center" rowspan="1" colspan="1">.444 &#8211; 1.107</td></tr><tr><td align="left" rowspan="1" colspan="1">Comorbidities</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Diabetes</td><td align="center" rowspan="1" colspan="1">1.109 &#8211; 3.422</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Congestive heart failure (CHF)</td><td align="center" rowspan="1" colspan="1">.200 &#8211; 1.213</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Peripheral vascular disease (PVD)</td><td align="center" rowspan="1" colspan="1">.634 &#8211; 3.237</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Renal disease</td><td align="center" rowspan="1" colspan="1">.641 &#8211; 6.802</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Moderate to severe liver disease</td><td align="center" rowspan="1" colspan="1">.009 &#8211; 1.082</td></tr><tr><td align="left" rowspan="1" colspan="1">Opioid Rx in 60 Days Prior to Surgery</td><td align="center" rowspan="1" colspan="1">1.226 &#8211; 3.649</td></tr><tr><td align="left" rowspan="1" colspan="1">Surgical Indication(s)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Cervical</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Disc herniation</td><td align="center" rowspan="1" colspan="1">.504 &#8211; 1.993</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Spondylolisthesis</td><td align="center" rowspan="1" colspan="1">.847 &#8211; 17.464</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Foraminal stenosis</td><td align="center" rowspan="1" colspan="1">.948 &#8211; 2.594</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Central stenosis</td><td align="center" rowspan="1" colspan="1">1.263 &#8211; 3.714</td></tr><tr><td align="left" rowspan="1" colspan="1">Lumbar</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Disc herniation</td><td align="center" rowspan="1" colspan="1">.365 &#8211; .987</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Spondylolisthesis</td><td align="center" rowspan="1" colspan="1">.710 &#8211; 1.938</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Foraminal stenosis</td><td align="center" rowspan="1" colspan="1">.805 &#8211; 1.926</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Central stenosis</td><td align="center" rowspan="1" colspan="1">.712 &#8211; 1.743</td></tr><tr><td align="left" rowspan="1" colspan="1">Lumbar</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;0 levels (decompression only)</td><td align="center" rowspan="1" colspan="1">.386 &#8211; .947</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;1-level</td><td align="center" rowspan="1" colspan="1">.449 &#8211; 1.434</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Multi-level</td><td align="center" rowspan="1" colspan="1">1.106 &#8211; 4.357</td></tr><tr><td align="left" rowspan="1" colspan="1">Cervical</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;0 levels (decompression only)</td><td align="center" rowspan="1" colspan="1">.216 &#8211; 4.636</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;1-level</td><td align="center" rowspan="1" colspan="1">.375 &#8211; 1.646</td></tr><tr><td align="left" rowspan="1" colspan="1">&#8195;Multi-level</td><td align="center" rowspan="1" colspan="1">1.314 &#8211; 4.047</td></tr><tr><td align="left" rowspan="1" colspan="1">Revision Surgery</td><td align="center" rowspan="1" colspan="1">.520 &#8211; 2.580</td></tr></tbody></table></alternatives></table-wrap></p><p>Multivariate logistic regression demonstrated that multi-level lumbar fusion (RR = 2.957, 95% CI: 1.126 &#8211; 4.788), cervical central stenosis (RR = 2.761, 95% CI: 1.343 &#8211; 4.179), and pre-operative opioid use (RR = 2.668, 95% CI: 1.283 &#8211; 4.052) were independent risk factors for opioid persistence following surgery.</p><p>Patients with persistent opioid use were more likely to have higher rates of healthcare utilization in the first year following surgery (<xref rid="fig1-21925682221104731" ref-type="fig">Figure 1</xref>, <xref rid="table5-21925682221104731" ref-type="table">Table 5</xref>). Specifically, these patients underwent a higher number of imaging studies &#8211; radiographs (<italic toggle="yes">P</italic> &lt; .001), computed tomography (CT) (<italic toggle="yes">P</italic> = .007), and magnetic resonance imaging (MRI) (<italic toggle="yes">P</italic> = .014) studies. They also had more visits to the emergency department (<italic toggle="yes">P</italic> = .009), more pain management referrals (<italic toggle="yes">P</italic> &lt; .001), and more epidural or other spinal injections (<italic toggle="yes">P</italic> = .003).<fig position="float" fig-type="figure" id="fig1-21925682221104731" orientation="portrait"><label>Figure 1.</label><caption><p>Differences in healthcare utilization between patients with and without opioid persistence after surgery. Differences in the mean number of (a) ED and urgent care visits, (b) imaging studies, and (c) opioid prescriptions within 1 year postoperatively. Note: * indicates statistical significance (<italic toggle="yes">P</italic> &lt; .05); ns = not significant.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="10.1177_21925682221104731-fig1.jpg"/></fig><table-wrap position="float" id="table5-21925682221104731" orientation="portrait"><label>Table 5.</label><caption><p>Healthcare Utilization by Patients in the Year Following Spine Surgery</p></caption><alternatives><graphic xmlns:xlink="http://www.w3.org/1999/xlink" specific-use="table5-21925682221104731" position="float" orientation="portrait" xlink:href="10.1177_21925682221104731-table5.jpg"/><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="2" colspan="1"/><th align="center" rowspan="1" colspan="1">No Opioid Persistence<sup>1</sup> [n = 486]</th><th align="center" rowspan="1" colspan="1">Opioid Persistence<sup>1</sup> [n = 97]</th><th align="center" rowspan="2" colspan="1">p</th></tr><tr><th align="center" rowspan="1" colspan="1">N &#177; S.D.</th><th align="center" rowspan="1" colspan="1">N &#177; S.D.</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">
<bold>Imaging Studies</bold>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Total # of XR studies</td><td align="center" rowspan="1" colspan="1">2.1 &#177; 2.1</td><td align="center" rowspan="1" colspan="1">3.1 &#177; 2.5</td><td align="center" rowspan="1" colspan="1">
<bold>&lt;.001</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Total # of CT studies</td><td align="center" rowspan="1" colspan="1">.1&#177; 0.4</td><td align="center" rowspan="1" colspan="1">.3 &#177; 0.6</td><td align="center" rowspan="1" colspan="1">
<bold>.007</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Total # of MR studies</td><td align="center" rowspan="1" colspan="1">.3 &#177; 0.6</td><td align="center" rowspan="1" colspan="1">.5 &#177; 0.7</td><td align="center" rowspan="1" colspan="1">
<bold>.014</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Emergency Department Visits</td><td align="center" rowspan="1" colspan="1">.2 &#177; 0.6</td><td align="center" rowspan="1" colspan="1">.8 &#177; 2.0</td><td align="center" rowspan="1" colspan="1">
<bold>.009</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Urgent Care Visits</td><td align="center" rowspan="1" colspan="1">.2 &#177; 0.5</td><td align="center" rowspan="1" colspan="1">.2 &#177; 0.6</td><td align="center" rowspan="1" colspan="1">.214</td></tr><tr><td align="left" rowspan="1" colspan="1">Pain Management Referrals</td><td align="center" rowspan="1" colspan="1">.1 &#177; 0.2</td><td align="center" rowspan="1" colspan="1">.3 &#177; 0.5</td><td align="center" rowspan="1" colspan="1">
<bold>&lt;.001</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Epidural or Other Spinal Injections</td><td align="center" rowspan="1" colspan="1">.1 &#177; 0.4</td><td align="center" rowspan="1" colspan="1">.4 &#177; 1.0</td><td align="center" rowspan="1" colspan="1">
<bold>.003</bold>
</td></tr></tbody></table></alternatives></table-wrap></p></sec><sec sec-type="discussion" id="sec15-21925682221104731"><title>Discussion</title><p>Through our single-institution cohort of 583 patients undergoing cervical or lumbar spine surgery, we found that patients with opioid persistence after surgery used more health care resources compared to their counterparts who weaned off all opioid medications by 6 months postoperatively. Persistent opioid users underwent more radiographs, CT scans, MRIs, and incurred more emergency department visits. Moreover, this group experienced more pain management referrals and received more epidural and spinal injections, contributing to an overall greater health care burden.</p><p>Our results showed an overall incidence of opioid persistence of 16.6% in patients undergoing spine surgery, with 5.5% in patients who underwent cervical spine surgery and 11.1% in patients who underwent lumbar spine surgery. Rates of opioid persistence for opioid-na&#239;ve patients vs prior opioid use patients were 17.5% and 82.4%, respectively. These findings reflect rates of opioid persistence reflected on other studies.<sup><xref rid="bibr8-21925682221104731" ref-type="bibr">8</xref>,<xref rid="bibr26-21925682221104731" ref-type="bibr">26</xref>-<xref rid="bibr29-21925682221104731" ref-type="bibr">29</xref></sup> Regarding lumbar spine surgery, Goyal et al found that 30% of patients undergoing posterior lumbar fusion and 19% of patients undergoing lumbar decompression experienced opioid persistence 6 month post-operatively. <sup>
<xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>
</sup> Notably, however, these authors found opioid persistence rates for opioid-na&#239;ve patients to be relatively lower, at 5.6% and 2.0% for opioid na&#239;ve patients undergoing lumbar fusion and decompression, respectively.<sup>
<xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>
</sup> Similarly, Connolly III et al reviewed 8377 patients who underwent lumbar fusion surgery and found that 29.9% experienced opioid persistence after surgery, with patients undergoing 360-degree fusion to be most likely to experience long-term opioid use. <sup>
<xref rid="bibr27-21925682221104731" ref-type="bibr">27</xref>
</sup> Uhrbrand et al conducted a prospective, single-center study of 300 patients and found that 7% of opioid-na&#239;ve and 51.5% of prior opioid use patients experience opioid persistence.<sup>
<xref rid="bibr8-21925682221104731" ref-type="bibr">8</xref>
</sup> Lastly, in their retrospective review of 5413 patients undergoing surgery for lumbar disc herniation, Karhade et al showed an overall opioid refill rate of 7.7% for all-comers between 90 and 180 days post-operatively.<sup>
<xref rid="bibr26-21925682221104731" ref-type="bibr">26</xref>
</sup></p><p>Regarding persistent opioid use after the cervical spine surgery, the literature suggests somewhat higher rates of opioid persistence. Pugely et al reviewed 17&#160;391 patients undergoing anterior cervical discectomy and fusion (ACDF) and posterior cervical fusion (PCF) and found 45.3% of prior opioid users and 6.3% of opioid-na&#239;ve patients experienced persistent opioid use at 1 year postoperatively. <sup>
<xref rid="bibr10-21925682221104731" ref-type="bibr">10</xref>
</sup> Similar rates of opioid persistence were reported by Wang et al, who found that 50.7% of prior opioid users and 17.5% of opioid-na&#239;ve patients reported ongoing opioid use after surgery for degenerative cervical conditions.<sup>
<xref rid="bibr30-21925682221104731" ref-type="bibr">30</xref>
</sup></p><p>Differences in opioid persistence rates between our study and previous studies may partially be explained by (1) differences in the definition of &#8220;opioid persistence&#8221;, (2) differences in methodology use to capture prescription data, and (3) state-by-state differences in drug monitoring program requirements during the study period during which opioid use data was captured. Regarding definitions of opioid persistence, most studies focused on 1 of 3 categories: patient-reported opioid use, number of prescription refills, or milliequivalent opioid refills after surgery. Within these categories, persistent opioid use can be further stratified. Per Goyal et al,<sup>
<xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>
</sup> common definitions include &#8220;additional use&#8221; or more than 1 opioid refill 90 to 180 days after surgery; <sup><xref rid="bibr4-21925682221104731" ref-type="bibr">4</xref>,<xref rid="bibr31-21925682221104731" ref-type="bibr">31</xref>,<xref rid="bibr32-21925682221104731" ref-type="bibr">32</xref></sup> &#8220;persistent use&#8221; or any span of opioid use starting 180 days after surgery and lasting more than 90 days;<sup><xref rid="bibr33-21925682221104731" ref-type="bibr">33</xref>,<xref rid="bibr34-21925682221104731" ref-type="bibr">34</xref></sup> or the Consortium to Study Opioid Risks and Trends (CONSORT) definition &#8211; which is persistent opioid use that includes either more than 10 opioid refills or more than 120-day supply of opioids.<sup><xref rid="bibr35-21925682221104731" ref-type="bibr">35</xref>,<xref rid="bibr36-21925682221104731" ref-type="bibr">36</xref></sup></p><p>We chose to follow patient filling prescriptions filled 180 days post-operatively but did not follow account for additional refills or doses due to limitations in our dataset. Additionally, strategies for capturing opioid use after surgery varies by research group, such as chart review vs pharmacy claims data. We constructed our data set primarily through algorithmic chart review and limited the definition of opioid medication to select medications. A more extensive definition of opioid medications and more robust capture through pharmacy claims data could affect findings for opioid use and opioid persistence after surgery. Lastly changes in state regulations for opioid monitoring programs and institutional level changes to opioid reduction initiatives may influence rates of opioid persistence. For example, a large insurance database study of more than 6 million patients prescribed opioids between 2011 and 2015 showed that comprehensive use of mandates to participate in drug monitoring programs reduced additional opioid prescriptions by 6 to 9%.<sup>
<xref rid="bibr37-21925682221104731" ref-type="bibr">37</xref>
</sup> With respect to surgery, a large cross-sectional study of more than 93&#160;000 patients undergoing general surgery, obstetric/gynecologic surgery, or orthopaedic surgery demonstrated initiation of a statewide drug monitor program was associated with an immediate decrease in opioid prescribed prescriptions across all 3 subspecialties. <sup>
<xref rid="bibr38-21925682221104731" ref-type="bibr">38</xref>
</sup></p><p>With respect to risk factors for persistent opioid use, we found risk to be multifactorial. Comparing the opioid-na&#239;ve vs opioid persistence groups, we found risk factors to include the following: obesity, ASA &#8805;3, diabetes, opioid prescription within 60 days preoperatively, patients with cervical stenosis, patients undergoing multi-level lumbar posterior spinal fusion, and patients undergoing multi-level cervical fusion. Additionally, our multivariate regression demonstrated that patients at increased risk of persistent opioid use are those with preoperative opioid use (RR = 2.7), with central cervical stenosis (RR = 2.8), or undergoing multilevel lumbar fusion (RR = 3.0).</p><p>Multiple studies have investigated risk factors for persistent opioid use after spine surgery. Patient-specific risk factors include younger age,<sup><xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>,<xref rid="bibr39-21925682221104731" ref-type="bibr">39</xref></sup> pre-operative opioid use,<sup><xref rid="bibr40-21925682221104731" ref-type="bibr">40</xref>,<xref rid="bibr41-21925682221104731" ref-type="bibr">41</xref></sup> mental health diagnoses,<sup><xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>,<xref rid="bibr40-21925682221104731" ref-type="bibr">40</xref>,<xref rid="bibr42-21925682221104731" ref-type="bibr">42</xref>-<xref rid="bibr44-21925682221104731" ref-type="bibr">44</xref></sup> smoking,<sup>
<xref rid="bibr42-21925682221104731" ref-type="bibr">42</xref>
</sup> chronic pain syndromes,<sup>
<xref rid="bibr42-21925682221104731" ref-type="bibr">42</xref>
</sup> socioecnomic status,<sup>
<xref rid="bibr43-21925682221104731" ref-type="bibr">43</xref>
</sup> and use of non-narcotic neuro-modulatory medications.<sup><xref rid="bibr42-21925682221104731" ref-type="bibr">42</xref>,<xref rid="bibr44-21925682221104731" ref-type="bibr">44</xref></sup> Surgery-specific risk factors are primarily related to include extent of surgery,<sup><xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>,<xref rid="bibr39-21925682221104731" ref-type="bibr">39</xref>,<xref rid="bibr40-21925682221104731" ref-type="bibr">40</xref></sup> such as multi-level fusion, discharge opioid greater than 500 morphine milliequivalents (MME),<sup>
<xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>
</sup> and prescription of long-acting opioids on discharge.<sup>
<xref rid="bibr28-21925682221104731" ref-type="bibr">28</xref>
</sup> Our findings support earlier studies, which demonstrated an association between preoperative opioid use or multi-level lumbar fusion and risk of postoperative opioid persistence. Our result showing an increased risk of opioid persistence in patients undergoing surgery for central cervical stenosis has not been previously reported in the literature. Approach for cervical decompression and fusion (ie, anterior vs posterior) may partially explain these results, as posterior-based procedures are typically associated with more significant neck pain compared to anterior-based procedures.<sup>
<xref rid="bibr45-21925682221104731" ref-type="bibr">45</xref>
</sup></p><p>We showed that these at-risk patients with persistent opioid use after cervical and lumbar spine surgery utilized significantly more health care resources compared to their counterparts who were either never prescribed opioids or successfully weaned off opioids by 6 months. Specifically, we found that this patient population makes more emergency department visits, undergoes more diagnostic imaging (ie, radiographs, CTs, and MRIs), receives more pain medicine referrals, and undergoes more spinal injections. To our knowledge, only 2 studies have specifically linked persistent opioid use with increased health care utilization after elective spine surgery. For example, a study of more than 10&#160;000 patients undergoing surgery for degenerative spondylolisthesis showed that patients with persistent opioid use were likely to incur about 2.8 times the overall costs of a patient who was never opioid dependent before or after surgery.<sup>
<xref rid="bibr16-21925682221104731" ref-type="bibr">16</xref>
</sup> The authors calculated this additional in cost to be between $11,660 and $12,039 per patient. A similar study of patients undergoing surgery for adult degenerative scoliosis demonstrated that patients with persistent opioid use incurred up to 3.03 times the costs of patients without prior opioid dependence of post-operative opioid persistence.<sup>
<xref rid="bibr15-21925682221104731" ref-type="bibr">15</xref>
</sup> They estimated the additional cost to be between $8077 and $27,404 per patient.</p><p>Our study adds to the limited body of literature regarding the relationship between persistent opioid use and postoperative health care utilization in 2 specific ways. First, prior studies focused on 1 specific type of spinal pathology, such as lumbar degenerative spondylolisthesis or scoliosis. Our study was the first, to our knowledge, to associate persistent opioid use after cervical spine surgery with increased health care utilization. Second, prior studies used overall cost as the primary outcome representative of health care utilization but did not stratify these costs by services provided. Our study breaks down health care utilization into key, billable points of contact with patients (ie, imaging studies, ED visits, etc.). These results can guide payers, providers, and policymakers in understanding where &#8211; in the chain of care delivery &#8211; persistent opioid use increases health care utilizations.</p><p>Efforts to minimize postoperative opioid use are underway at many institutions. For example, some hospitals are developing programs for enhanced recovery after surgery (ERAS), which aim to decrease overall complications and readmissions and ultimately improve recovery. This comprehensive approach to the preoperative, perioperative, and postoperative care has been shown to secondarily reduce opioid use after elective spine surgery.<sup>
<xref rid="bibr46-21925682221104731" ref-type="bibr">46</xref>
</sup> At Northwestern Memorial Hospital, the orthopaedic surgery department has leveraged the electronic medical record to provide recommended dose number and dosage amount for patients being discharged from the hospital. Residents, surgeons, and other health care practitioners are alerted of best practice opioid prescribed patterns for the relevant CPT codes upon patient admission or discharge. Lastly, surgeons in some Scandinavian countries are trialing postoperative, customized opioid tapering programs combined with telephone counseling to help mitigate issues of persistent opioid use after spine surgery.<sup><xref rid="bibr8-21925682221104731" ref-type="bibr">8</xref>,<xref rid="bibr14-21925682221104731" ref-type="bibr">14</xref>,<xref rid="bibr47-21925682221104731" ref-type="bibr">47</xref></sup></p><p>This study is not without limitations. First, this is a retrospective study of prospectively recorded data. Although we believe that our dataset captures more granular data compared to many large national registries and claims-based data sources, we are still limited by the scope of data recorded by our single institution. Second, we only captured diagnostics tests and medical / surgical services conducted at our institution and outside institutions that participate our collaborative health information exchange record system. Although the majority of hospital systems surrounding our institution participate in this information exchange platform, tests and services rendered outside of the systems may not be recorded. Furthermore, our analysis did not account for certain variables that would strengthen the generalizability of the study, such as insurance status, socioeconomic status, and patient-reported outcomes. Next, our study did not focus on the different classes or types of narcotic pain medication. We did not account for different doses or number of pills prescribed. Instead, we used the numbers of prescriptions written as proxy for these variables. Tracking MMEs vs prescription refills may be a more accurate means method for tracking opioid dependence and persistence post-operatively. Our available dataset limited our ability to use MMEs. We anticipate that future research efforts will track opioid persistence with MMEs and associate MMEs with health care utilization. The goal of these effort would be to find an inflection point at which a certain amount of MME preoperatively, perioperatively, or postoperatively predicts opioid persistence and impact health care utilization.</p></sec><sec sec-type="conclusion" id="sec16-21925682221104731"><title>Conclusion</title><p>One-in-six patients undergoing elective spine surgery of the cervical or lumbar spine experience persistent opioid use at 6 months postoperatively. Patients with preoperative opioid use, those undergoing surgery for cervical stenosis, and those undergoing multi-level fusion were at highest risk for persistent opioid use. Moreover, those with persistent opioid use utilized more health care resources and services within 1 year postoperatively. Efforts to curb the rising costs of health care must include interventions that target inappropriate opioid use before and after elective spine surgery.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The author(s) received no financial support for the research, authorship, and/or publication of this article.</p></fn></fn-group><sec id="sec17-21925682221104731"><title>ORCID iDs</title><p>Erik B. Gerlach <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-5992-9119" ext-link-type="uri">https://orcid.org/0000-0002-5992-9119</ext-link></p><p>David Fei-Zhang <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-4485-8274" ext-link-type="uri">https://orcid.org/0000-0002-4485-8274</ext-link></p><p>Srikanth N. Divi <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://orcid.org/0000-0002-5776-2044" ext-link-type="uri">https://orcid.org/0000-0002-5776-2044</ext-link></p></sec><ref-list><title>References</title><ref id="bibr1-21925682221104731"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Florence</surname><given-names>C</given-names></name><name name-style="western"><surname>Luo</surname><given-names>F</given-names></name><name name-style="western"><surname>Rice</surname><given-names>K</given-names></name></person-group>. <article-title>The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017</article-title>. <source>Drug and Alcohol Dependence</source>. <year>2021</year>;<volume>218</volume>:<fpage>108350</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.drugalcdep.2020.108350</pub-id><pub-id pub-id-type="pmid">33121867</pub-id><pub-id pub-id-type="pmcid">PMC8091480</pub-id></mixed-citation></ref><ref id="bibr2-21925682221104731"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vadivelu</surname><given-names>N</given-names></name><name name-style="western"><surname>Kai</surname><given-names>AM</given-names></name><name name-style="western"><surname>Kodumudi</surname><given-names>V</given-names></name><name name-style="western"><surname>Sramcik</surname><given-names>J</given-names></name><name name-style="western"><surname>Kaye</surname><given-names>AD</given-names></name></person-group>. <article-title>The opioid crisis: A comprehensive overview</article-title>. <source>Current Pain and Headache Reports</source>. <year>2018</year>;<volume>22</volume>(<issue>3</issue>):<fpage>16</fpage>. doi:<pub-id pub-id-type="doi">10.1007/s11916-018-0670-z</pub-id><pub-id pub-id-type="pmid">29476358</pub-id></mixed-citation></ref><ref id="bibr3-21925682221104731"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dunn</surname><given-names>LK</given-names></name><name name-style="western"><surname>Yerra</surname><given-names>S</given-names></name><name name-style="western"><surname>Fang</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Incidence and risk factors for chronic postoperative opioid use after major spine surgery: A cross-sectional study with longitudinal outcome</article-title>. <source>Anesthesia and Analgesia</source>. <year>2018</year>;<volume>127</volume>(<issue>1</issue>):<fpage>247</fpage>-<lpage>254</lpage>. doi:<pub-id pub-id-type="doi">10.1213/ANE.0000000000003338</pub-id><pub-id pub-id-type="pmid">29570151</pub-id><pub-id pub-id-type="pmcid">PMC6487073</pub-id></mixed-citation></ref><ref id="bibr4-21925682221104731"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brummett</surname><given-names>CM</given-names></name><name name-style="western"><surname>Waljee</surname><given-names>JF</given-names></name><name name-style="western"><surname>Goesling</surname><given-names>J</given-names></name></person-group>, <etal>et al.</etal><article-title>New persistent opioid use after minor and major surgical procedures in us adults</article-title>. <source>JAMA Surgery</source>. <year>2017</year>;<volume>152</volume>(<issue>6</issue>):<fpage>e170504</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamasurg.2017.0504</pub-id><pub-id pub-id-type="pmid">28403427</pub-id><pub-id pub-id-type="pmcid">PMC7050825</pub-id></mixed-citation></ref><ref id="bibr5-21925682221104731"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Neuman</surname><given-names>MD</given-names></name><name name-style="western"><surname>Bateman</surname><given-names>BT</given-names></name><name name-style="western"><surname>Wunsch</surname><given-names>H</given-names></name></person-group>. <article-title>Inappropriate opioid prescription after surgery</article-title>. <source>The Lancet</source>. <year>2019</year>;<volume>393</volume>(<issue>10180</issue>):<fpage>1547</fpage>-<lpage>1557</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(19)30428-3</pub-id><pub-id pub-id-type="pmcid">PMC6556783</pub-id><pub-id pub-id-type="pmid">30983590</pub-id></mixed-citation></ref><ref id="bibr6-21925682221104731"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>AB</given-names></name><name name-style="western"><surname>Marrache</surname><given-names>M</given-names></name><name name-style="western"><surname>Puvanesarajah</surname><given-names>V</given-names></name></person-group>, <etal>et al.</etal><article-title>Are preoperative depression and anxiety associated with patient-reported outcomes, health care payments, and opioid use after anterior discectomy and fusion?</article-title><source>Spine Journal</source>. <year>2020</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1167</fpage>-<lpage>1175</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.spinee.2020.03.004</pub-id><pub-id pub-id-type="pmid">32179156</pub-id></mixed-citation></ref><ref id="bibr7-21925682221104731"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>EC</given-names></name><name name-style="western"><surname>Darnall</surname><given-names>BD</given-names></name><name name-style="western"><surname>Baker</surname><given-names>LC</given-names></name><name name-style="western"><surname>MacKey</surname><given-names>S</given-names></name></person-group>. <article-title>Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period</article-title>. <source>JAMA Internal Medicine</source>. <year>2016</year>;<volume>176</volume>(<issue>9</issue>):<fpage>1286</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamainternmed.2016.3298</pub-id><pub-id pub-id-type="pmid">27400458</pub-id><pub-id pub-id-type="pmcid">PMC6684468</pub-id></mixed-citation></ref><ref id="bibr8-21925682221104731"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uhrbrand</surname><given-names>P</given-names></name><name name-style="western"><surname>Helmig</surname><given-names>P</given-names></name><name name-style="western"><surname>Haroutounian</surname><given-names>S</given-names></name><name name-style="western"><surname>Vistisen</surname><given-names>ST</given-names></name><name name-style="western"><surname>Nikolajsen</surname><given-names>L</given-names></name></person-group>. <article-title>Persistent opioid use after spine surgery</article-title>. <source>Spine</source>. <year>2021</year>(<issue>20</issue>):<fpage>46</fpage>-<lpage>1435</lpage>. doi:<pub-id pub-id-type="doi">10.1097/brs.0000000000004039</pub-id><pub-id pub-id-type="pmid">34559754</pub-id></mixed-citation></ref><ref id="bibr9-21925682221104731"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohan</surname><given-names>S</given-names></name><name name-style="western"><surname>Lynch</surname><given-names>CP</given-names></name><name name-style="western"><surname>Cha</surname><given-names>EDK</given-names></name></person-group>, <etal>et al.</etal><article-title>Baseline risk factors for prolonged opioid use following spine surgery: systematic review and meta-analysis</article-title>. <source>World Neurosurg</source>. <year>2022</year>;<volume>159</volume>:<fpage>179</fpage>-<lpage>188.e2</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.wneu.2021.12.086</pub-id><pub-id pub-id-type="pmid">34971835</pub-id></mixed-citation></ref><ref id="bibr10-21925682221104731"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pugely</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Bedard</surname><given-names>NA</given-names></name><name name-style="western"><surname>Kalakoti</surname><given-names>P</given-names></name></person-group>, <etal>et al.</etal><article-title>Opioid use following cervical spine surgery: trends and factors associated with long-term use</article-title>. <source>Spine Journal</source>. <year>2018</year>;<volume>18</volume>(<issue>11</issue>):<fpage>1974</fpage>-<lpage>1981</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.spinee.2018.03.018</pub-id><pub-id pub-id-type="pmid">29653244</pub-id></mixed-citation></ref><ref id="bibr11-21925682221104731"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cook</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Kaskovich</surname><given-names>S</given-names></name><name name-style="western"><surname>Pirkle</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Benchmarks of duration and magnitude of opioid consumption after common spinal procedures: A database analysis of 47,823 patients</article-title>. <source>Spine</source>. <year>2019</year>;<volume>44</volume>(<issue>23</issue>):<fpage>1668</fpage>-<lpage>1675</lpage>. doi:<pub-id pub-id-type="doi">10.1097/BRS.0000000000003141</pub-id><pub-id pub-id-type="pmid">31730572</pub-id></mixed-citation></ref><ref id="bibr12-21925682221104731"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stark</surname><given-names>N</given-names></name><name name-style="western"><surname>Kerr</surname><given-names>S</given-names></name><name name-style="western"><surname>Stevens</surname><given-names>J</given-names></name></person-group>. <article-title>Prevalence and predictors of persistent post-surgical opioid use: A prospective observational cohort study</article-title>. <source>Anaesthesia and Intensive Care</source>. <year>2017</year>;<volume>45</volume>(<issue>6</issue>):<fpage>700</fpage>-<lpage>706</lpage>. doi:<pub-id pub-id-type="doi">10.1177/0310057X1704500609</pub-id><pub-id pub-id-type="pmid">29137580</pub-id></mixed-citation></ref><ref id="bibr13-21925682221104731"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>SG</given-names></name><name name-style="western"><surname>Paterniti</surname><given-names>DA</given-names></name><name name-style="western"><surname>Feng</surname><given-names>B</given-names></name></person-group>, <etal>et al.</etal><article-title>Patients&#8217; experience with opioid tapering: A conceptual model with recommendations for clinicians</article-title>. <source>Journal of Pain</source>. <year>2019</year>;<volume>20</volume>(<issue>2</issue>):<fpage>181</fpage>-<lpage>191</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpain.2018.09.001</pub-id><pub-id pub-id-type="pmid">30243859</pub-id><pub-id pub-id-type="pmcid">PMC6349552</pub-id></mixed-citation></ref><ref id="bibr14-21925682221104731"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uhrbrand</surname><given-names>P</given-names></name><name name-style="western"><surname>Phillipsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Dreyer</surname><given-names>P</given-names></name><name name-style="western"><surname>Nikolajsen</surname><given-names>L</given-names></name></person-group>. <article-title>Opioid tapering after surgery: A qualitative study of patients&#8217; experiences</article-title>. <source>Scandinavian Journal of Pain</source>. <year>2020</year>;<volume>20</volume>(<issue>3</issue>):<fpage>555</fpage>-<lpage>563</lpage>. doi:<pub-id pub-id-type="doi">10.1515/sjpain-2019-0168</pub-id><pub-id pub-id-type="pmid">32338635</pub-id></mixed-citation></ref><ref id="bibr15-21925682221104731"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name><name name-style="western"><surname>Ugiliweneza</surname><given-names>B</given-names></name><name name-style="western"><surname>Sirdeshpande</surname><given-names>P</given-names></name><name name-style="western"><surname>Wang</surname><given-names>D</given-names></name><name name-style="western"><surname>Boakye</surname><given-names>M</given-names></name></person-group>. <article-title>Opioid dependence and health care utilization after decompression and fusion in patients with adult degenerative scoliosis</article-title>. <source>Spine</source>. <year>2019</year>;<volume>44</volume>(<issue>4</issue>):<fpage>280</fpage>-<lpage>290</lpage>. doi:<pub-id pub-id-type="doi">10.1097/BRS.0000000000002794</pub-id><pub-id pub-id-type="pmid">30015717</pub-id></mixed-citation></ref><ref id="bibr16-21925682221104731"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name><name name-style="western"><surname>Ugiliweneza</surname><given-names>B</given-names></name><name name-style="western"><surname>Aljuboori</surname><given-names>Z</given-names></name><name name-style="western"><surname>Boakye</surname><given-names>M</given-names></name></person-group>. <article-title>Health care utilization and overall costs based on opioid dependence in patients undergoing surgery for degenerative spondylolisthesis</article-title>. <source>Neurosurgical Focus</source>. <year>2018</year>;<volume>44</volume>(<issue>5</issue>):<fpage>E14</fpage>. doi:<pub-id pub-id-type="doi">10.3171/2018.2.FOCUS17764</pub-id><pub-id pub-id-type="pmid">29712535</pub-id></mixed-citation></ref><ref id="bibr17-21925682221104731"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charlson</surname><given-names>ME</given-names></name><name name-style="western"><surname>Charlson</surname><given-names>RE</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>JC</given-names></name><name name-style="western"><surname>Marinopoulos</surname><given-names>SS</given-names></name><name name-style="western"><surname>Briggs</surname><given-names>WM</given-names></name><name name-style="western"><surname>Hollenberg</surname><given-names>JP</given-names></name></person-group>. <article-title>The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients</article-title>. <source>Journal of Clinical Epidemiology</source>. <year>2008</year>;<volume>61</volume>(<issue>12</issue>):<fpage>1234</fpage>-<lpage>1240</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jclinepi.2008.01.006</pub-id><pub-id pub-id-type="pmid">18619805</pub-id></mixed-citation></ref><ref id="bibr18-21925682221104731"><label>18</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Weir</surname><given-names>CB</given-names></name><name name-style="western"><surname>Jan</surname><given-names>A</given-names></name></person-group>. <comment>BMI Classification Percentile And Cut Off Points</comment>.; <year>2019</year></mixed-citation></ref><ref id="bibr19-21925682221104731"><label>19</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Doyle</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Garmon</surname><given-names>EH</given-names></name></person-group>. <comment>American Society of Anesthesiologists Classification (ASA Class).</comment>; <year>2018</year></mixed-citation></ref><ref id="bibr20-21925682221104731"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wolters</surname><given-names>U</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>T</given-names></name><name name-style="western"><surname>St&#252;tzer</surname><given-names>H</given-names></name><name name-style="western"><surname>Schr&#246;der</surname><given-names>T</given-names></name></person-group>. <article-title>ASA classification and perioperative variables as predictors of postoperative outcome</article-title>. <source>British Journal of Anaesthesia</source>. <year>1996</year>;<volume>77</volume>(<issue>2</issue>):<fpage>217</fpage>-<lpage>222</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bja/77.2.217</pub-id><pub-id pub-id-type="pmid">8881629</pub-id></mixed-citation></ref><ref id="bibr21-21925682221104731"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Charlson</surname><given-names>M</given-names></name><name name-style="western"><surname>Szatrowski</surname><given-names>TP</given-names></name><name name-style="western"><surname>Peterson</surname><given-names>J</given-names></name><name name-style="western"><surname>Gold</surname><given-names>J</given-names></name></person-group>. <article-title>Validation of a combined comorbidity index</article-title>. <source>Journal of Clinical Epidemiology</source>. <year>1994</year>;<volume>47</volume>(<issue>11</issue>):<fpage>1245</fpage>-<lpage>1251</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0895-4356(94)90129-5</pub-id><pub-id pub-id-type="pmid">7722560</pub-id></mixed-citation></ref><ref id="bibr22-21925682221104731"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Voskuijl</surname><given-names>T</given-names></name><name name-style="western"><surname>Hageman</surname><given-names>M</given-names></name><name name-style="western"><surname>Ring</surname><given-names>D</given-names></name></person-group>. <article-title>Higher Charlson comorbidity index scores are associated with readmission after orthopaedic surgery</article-title>. <source>Clinical Orthopaedics and Related Research</source>. <year>2014</year>;<volume>472</volume>(<issue>5</issue>):<fpage>1638</fpage>-<lpage>1644</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11999-013-3394-8</pub-id><pub-id pub-id-type="pmid">24276857</pub-id><pub-id pub-id-type="pmcid">PMC3971213</pub-id></mixed-citation></ref><ref id="bibr23-21925682221104731"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kirkland</surname><given-names>LL</given-names></name><name name-style="western"><surname>Kashiwagi</surname><given-names>DT</given-names></name><name name-style="western"><surname>Burton</surname><given-names>MC</given-names></name><name name-style="western"><surname>Cha</surname><given-names>S</given-names></name><name name-style="western"><surname>Varkey</surname><given-names>P</given-names></name></person-group>. <article-title>The charlson comorbidity index score as a predictor of 30-day mortality after hip fracture surgery</article-title>. <source>American Journal of Medical Quality</source>. <year>2011</year>;<volume>26</volume>(<issue>6</issue>):<fpage>461</fpage>-<lpage>467</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1062860611402188</pub-id><pub-id pub-id-type="pmid">21450939</pub-id></mixed-citation></ref><ref id="bibr24-21925682221104731"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitmore</surname><given-names>RG</given-names></name><name name-style="western"><surname>Stephen</surname><given-names>JH</given-names></name><name name-style="western"><surname>Vernick</surname><given-names>C</given-names></name></person-group>, <etal>et al.</etal><article-title>ASA grade and Charlson Comorbidity Index of spinal surgery patients: Correlation with complications and societal costs</article-title>. <source>Spine Journal</source>. <year>2014</year>;<volume>14</volume>(<issue>1</issue>):<fpage>31</fpage>-<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.spinee.2013.03.011</pub-id><pub-id pub-id-type="pmid">23602377</pub-id></mixed-citation></ref><ref id="bibr25-21925682221104731"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>C</given-names></name><name name-style="western"><surname>Mostashari</surname><given-names>F</given-names></name><name name-style="western"><surname>Mertz</surname><given-names>K</given-names></name><name name-style="western"><surname>Hogin</surname><given-names>E</given-names></name><name name-style="western"><surname>Atwal</surname><given-names>P</given-names></name></person-group>. <article-title>From the office of the national coordinator: The strategy for advancing the exchange of health information</article-title>. <source>Health Affairs</source>. <year>2012</year>;<volume>31</volume>(<issue>3</issue>):<fpage>527</fpage>-<lpage>536</lpage>. doi:<pub-id pub-id-type="doi">10.1377/hlthaff.2011.1314</pub-id><pub-id pub-id-type="pmid">22392663</pub-id></mixed-citation></ref><ref id="bibr26-21925682221104731"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karhade</surname><given-names>A v</given-names></name><name name-style="western"><surname>Ogink</surname><given-names>PT</given-names></name><name name-style="western"><surname>Thio</surname><given-names>QCBS</given-names></name></person-group>, <etal>et al.</etal><article-title>Development of machine learning algorithms for prediction of prolonged opioid prescription after surgery for lumbar disc herniation</article-title>. <source>Spine Journal</source>. <year>2019</year>;<volume>19</volume>(<issue>11</issue>):<fpage>1764</fpage>-<lpage>1771</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.spinee.2019.06.002</pub-id><pub-id pub-id-type="pmid">31185292</pub-id></mixed-citation></ref><ref id="bibr27-21925682221104731"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Connolly</surname><given-names>J</given-names></name><name name-style="western"><surname>Javed</surname><given-names>Z</given-names></name><name name-style="western"><surname>Raji</surname><given-names>MA</given-names></name><name name-style="western"><surname>Chan</surname><given-names>W</given-names></name><name name-style="western"><surname>Kuo</surname><given-names>YF</given-names></name><name name-style="western"><surname>Baillargeon</surname><given-names>J</given-names></name></person-group>. <article-title>Predictors of long-term opioid use following lumbar fusion surgery</article-title>. <source>Spine</source>. <year>2017</year>;<volume>42</volume>(<issue>18</issue>):<fpage>1405</fpage>-<lpage>1411</lpage>. doi:<pub-id pub-id-type="doi">10.1097/BRS.0000000000002133</pub-id><pub-id pub-id-type="pmid">28263225</pub-id><pub-id pub-id-type="pmcid">PMC5582019</pub-id></mixed-citation></ref><ref id="bibr28-21925682221104731"><label>28</label><mixed-citation publication-type="other"><person-group person-group-type="author"><name name-style="western"><surname>Goyal</surname><given-names>A</given-names></name><name name-style="western"><surname>Payne</surname><given-names>S</given-names></name><name name-style="western"><surname>Sangaralingham</surname><given-names>LR</given-names></name></person-group>, <etal>et al.</etal><article-title>Incidence and risk factors for prolonged postoperative opioid use following lumbar spine surgery: a cohort study</article-title>. <source>Journal of Neurosurgery: Spine</source>. <comment>Published online 2021</comment>. doi:<pub-id pub-id-type="doi">10.3171/2021.2.spine202205</pub-id><pub-id pub-id-type="pmid">34359026</pub-id></mixed-citation></ref><ref id="bibr29-21925682221104731"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vraa</surname><given-names>ML</given-names></name><name name-style="western"><surname>Myers</surname><given-names>CA</given-names></name><name name-style="western"><surname>Young</surname><given-names>JL</given-names></name><name name-style="western"><surname>Rhon</surname><given-names>DI</given-names></name></person-group>. <article-title>More Than 1 in 3 Patients With Chronic Low Back Pain Continue to Use Opioids Long-term After Spinal Fusion: A Systematic Review</article-title>. <source>Clin J Pain</source>. <year>2021</year>;<volume>38</volume>(<issue>3</issue>):<fpage>222</fpage>-<lpage>230</lpage>. doi:<pub-id pub-id-type="doi">10.1097/AJP.0000000000001006</pub-id><pub-id pub-id-type="pmid">34856579</pub-id></mixed-citation></ref><ref id="bibr30-21925682221104731"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>MC</given-names></name><name name-style="western"><surname>Lozen</surname><given-names>AM</given-names></name><name name-style="western"><surname>Laud</surname><given-names>PW</given-names></name><name name-style="western"><surname>Nattinger</surname><given-names>AB</given-names></name><name name-style="western"><surname>Krebs</surname><given-names>EE</given-names></name></person-group>. <article-title>Factors associated with chronic opioid use after cervical spine surgery for degenerative conditions</article-title>. <source>Journal of Neurosurgery: Spine</source>. <year>2020</year>;<volume>32</volume>(<issue>1</issue>)-<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.3171/2019.7.SPINE19563</pub-id><pub-id pub-id-type="pmid">31604325</pub-id></mixed-citation></ref><ref id="bibr31-21925682221104731"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>M</given-names></name><name name-style="western"><surname>Barber</surname><given-names>CW</given-names></name><name name-style="western"><surname>Leatherman</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy</article-title>. <source>JAMA Internal Medicine</source>. <year>2015</year>;<volume>175</volume>(<issue>4</issue>):<fpage>608</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamainternmed.2014.8071</pub-id><pub-id pub-id-type="pmid">25686208</pub-id></mixed-citation></ref><ref id="bibr32-21925682221104731"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karhade</surname><given-names>A v</given-names></name><name name-style="western"><surname>Ogink</surname><given-names>PT</given-names></name><name name-style="western"><surname>Thio</surname><given-names>QCBS</given-names></name></person-group>, <etal>et al.</etal><article-title>Machine learning for prediction of sustained opioid prescription after anterior cervical discectomy and fusion</article-title>. <source>Spine Journal</source>. <year>2019</year>;<volume>19</volume>(<issue>6</issue>):<fpage>976</fpage>-<lpage>983</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.spinee.2019.01.009</pub-id><pub-id pub-id-type="pmid">30710731</pub-id></mixed-citation></ref><ref id="bibr33-21925682221104731"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilsey</surname><given-names>BL</given-names></name><name name-style="western"><surname>Fishman</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>CS</given-names></name><name name-style="western"><surname>Storment</surname><given-names>J</given-names></name><name name-style="western"><surname>Albanese</surname><given-names>A</given-names></name></person-group>. <article-title>Markers of abuse liability of short- vs long-acting opioids in chronic pain patients: A randomized cross-over trial</article-title>. <source>Pharmacology Biochemistry and Behavior</source>. <year>2009</year>;<volume>94</volume>(<issue>1</issue>):<fpage>98</fpage>-<lpage>107</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.pbb.2009.07.014</pub-id><pub-id pub-id-type="pmid">19660492</pub-id><pub-id pub-id-type="pmcid">PMC2757543</pub-id></mixed-citation></ref><ref id="bibr34-21925682221104731"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habermann</surname><given-names>EB</given-names></name></person-group>. <article-title>Are Opioids Overprescribed Following Elective Surgery?</article-title><source>Advances in Surgery</source>. <year>2018</year>;<volume>52</volume>(<issue>1</issue>):<fpage>247</fpage>-<lpage>256</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.yasu.2018.03.003</pub-id><pub-id pub-id-type="pmid">30098616</pub-id></mixed-citation></ref><ref id="bibr35-21925682221104731"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Armaghani</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Lee</surname><given-names>DS</given-names></name><name name-style="western"><surname>Bible</surname><given-names>JE</given-names></name></person-group>, <etal>et al.</etal><article-title>Preoperative narcotic use and its relation to depression and anxiety in patients undergoing spine surgery</article-title>. <source>Spine (Phila Pa 1976)</source>. <year>2013</year>;<volume>38</volume>(<issue>25</issue>):<fpage>2196</fpage>-<lpage>2200</lpage>. doi:<pub-id pub-id-type="doi">10.1097/BRS.0000000000000011</pub-id><pub-id pub-id-type="pmid">24296482</pub-id></mixed-citation></ref><ref id="bibr36-21925682221104731"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clarke</surname><given-names>H</given-names></name><name name-style="western"><surname>Soneji</surname><given-names>N</given-names></name><name name-style="western"><surname>Ko</surname><given-names>DT</given-names></name><name name-style="western"><surname>Yun</surname><given-names>L</given-names></name><name name-style="western"><surname>Wijeysundera</surname><given-names>DN</given-names></name></person-group>. <article-title>Rates and risk factors for prolonged opioid use after major surgery: Population based cohort study</article-title>. <source>BMJ (Online)</source>. <year>2014</year>;<volume>348</volume>:<fpage>g1251</fpage>. doi:<pub-id pub-id-type="doi">10.1136/bmj.g1251</pub-id><pub-id pub-id-type="pmcid">PMC3921439</pub-id><pub-id pub-id-type="pmid">24519537</pub-id></mixed-citation></ref><ref id="bibr37-21925682221104731"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bao</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wen</surname><given-names>K</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>P</given-names></name><name name-style="western"><surname>Jeng</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Meisel</surname><given-names>ZF</given-names></name><name name-style="western"><surname>Schackman</surname><given-names>BR</given-names></name></person-group>. <article-title>Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions</article-title>. <source>Health Affairs</source>. <year>2018</year>;<volume>37</volume>(<issue>10</issue>):<fpage>1596</fpage>-<lpage>1604</lpage>. doi:<pub-id pub-id-type="doi">10.1377/hlthaff.2018.0512</pub-id><pub-id pub-id-type="pmid">30273045</pub-id><pub-id pub-id-type="pmcid">PMC6362993</pub-id></mixed-citation></ref><ref id="bibr38-21925682221104731"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shenoy</surname><given-names>R</given-names></name><name name-style="western"><surname>Wagner</surname><given-names>Z</given-names></name><name name-style="western"><surname>Kirkegaard</surname><given-names>A</given-names></name></person-group>, <etal>et al.</etal><article-title>Assessment of postoperative opioid prescriptions before and after implementation of a mandatory prescription drug monitoring program</article-title>. <source>JAMA Health Forum</source>. <year>2021</year>;<volume>2</volume>(<issue>10</issue>):<fpage>e212924</fpage>. doi:<pub-id pub-id-type="doi">10.1001/jamahealthforum.2021.2924</pub-id><pub-id pub-id-type="pmid">35977161</pub-id><pub-id pub-id-type="pmcid">PMC8725834</pub-id></mixed-citation></ref><ref id="bibr39-21925682221104731"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendoza-Elias</surname><given-names>N</given-names></name><name name-style="western"><surname>Dunbar</surname><given-names>M</given-names></name><name name-style="western"><surname>Ghogawala</surname><given-names>Z</given-names></name><name name-style="western"><surname>Whitmore</surname><given-names>RG</given-names></name></person-group>. <article-title>Opioid use, risk factors, and outcome in lumbar fusion surgery</article-title>. <source>World Neurosurgery</source>. <year>2020</year>;<volume>135</volume>:<fpage>e580</fpage>-<lpage>e587</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.wneu.2019.12.073</pub-id><pub-id pub-id-type="pmid">31870819</pub-id></mixed-citation></ref><ref id="bibr40-21925682221104731"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montgomery</surname><given-names>EY</given-names></name><name name-style="western"><surname>Pernik</surname><given-names>MN</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>ZD</given-names></name></person-group>, <etal>et al.</etal><article-title>Perioperative factors associated with chronic opioid use after spine surgery</article-title>. <source>Global Spine Journal</source>. <year>2021</year>:<fpage>219256822110357</fpage>. <comment>Published online</comment>. doi:<pub-id pub-id-type="doi">10.1177/21925682211035723</pub-id><pub-id pub-id-type="pmcid">PMC10448093</pub-id><pub-id pub-id-type="pmid">34414800</pub-id></mixed-citation></ref><ref id="bibr41-21925682221104731"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rosenthal</surname><given-names>BD</given-names></name><name name-style="western"><surname>Suleiman</surname><given-names>LI</given-names></name><name name-style="western"><surname>Kannan</surname><given-names>A</given-names></name><name name-style="western"><surname>Edelstein</surname><given-names>AI</given-names></name><name name-style="western"><surname>Hsu</surname><given-names>WK</given-names></name><name name-style="western"><surname>Patel</surname><given-names>AA</given-names></name></person-group>. <article-title>Risk factors for prolonged postoperative opioid use after spine surgery: A review of dispensation trends from a state-run prescription Monitoring Program</article-title>. <source>Journal of the American Academy of Orthopaedic Surgeons</source>. <year>2019</year>;<volume>27</volume>(<issue>1</issue>):<fpage>32</fpage>-<lpage>38</lpage>. doi:<pub-id pub-id-type="doi">10.5435/JAAOS-D-17-00304</pub-id><pub-id pub-id-type="pmid">30199478</pub-id></mixed-citation></ref><ref id="bibr42-21925682221104731"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kowalski</surname><given-names>C</given-names></name><name name-style="western"><surname>Ridenour</surname><given-names>R</given-names></name><name name-style="western"><surname>McNutt</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Risk factors for prolonged opioid use after spine surgery</article-title>. <source>Global Spine Journal</source>. <year>2021</year>:<fpage>219256822110038</fpage>. <comment>Published online</comment>. doi:<pub-id pub-id-type="doi">10.1177/21925682211003854</pub-id><pub-id pub-id-type="pmcid">PMC10240594</pub-id><pub-id pub-id-type="pmid">33853404</pub-id></mixed-citation></ref><ref id="bibr43-21925682221104731"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schoenfeld</surname><given-names>AJ</given-names></name><name name-style="western"><surname>Nwosu</surname><given-names>K</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>W</given-names></name></person-group>, <etal>et al.</etal><article-title>Risk factors for prolonged opioid use following spine surgery, and the association with surgical intensity, among opioid-naive patients</article-title>. <source>Journal of Bone and Joint Surgery - American</source>. <year>2017</year>;<volume>99</volume>(<issue>15</issue>):<fpage>1247</fpage>-<lpage>1252</lpage>. doi:<pub-id pub-id-type="doi">10.2106/JBJS.16.01075</pub-id><pub-id pub-id-type="pmid">28763410</pub-id></mixed-citation></ref><ref id="bibr44-21925682221104731"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karhade</surname><given-names>A v</given-names></name><name name-style="western"><surname>Cha</surname><given-names>TD</given-names></name><name name-style="western"><surname>Fogel</surname><given-names>HA</given-names></name></person-group>, <etal>et al.</etal><article-title>Predicting prolonged opioid prescriptions in opioid-na&#239;ve lumbar spine surgery patients</article-title>. <source>Spine Journal</source>. <year>2020</year>;<volume>20</volume>:<fpage>888</fpage>-<lpage>895</lpage>. <comment>Published online</comment>. doi:<pub-id pub-id-type="doi">10.1016/j.spinee.2019.12.019</pub-id><pub-id pub-id-type="pmid">31901553</pub-id></mixed-citation></ref><ref id="bibr45-21925682221104731"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>El-Ghandour</surname><given-names>NMF</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>MAR</given-names></name><name name-style="western"><surname>Ezzat</surname><given-names>AAM</given-names></name><name name-style="western"><surname>Mohsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Zein-Elabedin</surname><given-names>M</given-names></name></person-group>. <article-title>The safety and efficacy of anterior versus posterior decompression surgery in degenerative cervical myelopathy: a prospective randomized trial</article-title>. <source>Journal of Neurosurgery: Spine</source>;<volume>33</volume>:<fpage>2020</fpage>-<lpage>2296</lpage>. doi:<pub-id pub-id-type="doi">10.3171/2020.2.SPINE191272</pub-id><pub-id pub-id-type="pmid">32357329</pub-id></mixed-citation></ref><ref id="bibr46-21925682221104731"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dietz</surname><given-names>N</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>M</given-names></name><name name-style="western"><surname>Adams</surname><given-names>S</given-names></name></person-group>, <etal>et al.</etal><article-title>Enhanced recovery after surgery (ERAS) for spine surgery: A systematic review</article-title>. <source>World Neurosurgery</source>. <year>2019</year>;<volume>130</volume>:<fpage>415</fpage>-<lpage>426</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.wneu.2019.06.181</pub-id><pub-id pub-id-type="pmid">31276851</pub-id></mixed-citation></ref><ref id="bibr47-21925682221104731"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uhrbrand</surname><given-names>P</given-names></name><name name-style="western"><surname>Phillipsen</surname><given-names>A</given-names></name><name name-style="western"><surname>Rasmussen</surname><given-names>MM</given-names></name><name name-style="western"><surname>Nikolajsen</surname><given-names>L</given-names></name></person-group>. <article-title>Opioid tapering after spine surgery: Protocol for a randomized controlled trial</article-title>. <source>Acta Anaesthesiologica Scandinavica</source>. <year>2020</year>;<volume>64</volume>(<issue>7</issue>):<fpage>1021</fpage>-<lpage>1024</lpage>. doi:<pub-id pub-id-type="doi">10.1111/aas.13576</pub-id><pub-id pub-id-type="pmid">32157678</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>